204 related articles for article (PubMed ID: 20931272)
1. Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
Kishida D; Okuda Y; Onishi M; Takebayashi M; Matoba K; Jouyama K; Yamada A; Sawada N; Mokuda S; Takasugi K
Mod Rheumatol; 2011 Apr; 21(2):215-8. PubMed ID: 20931272
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
Forestier E; Pasquali JL
Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
[No Abstract] [Full Text] [Related]
3. Tocilizumab in adult-onset Still's disease: the Israeli experience.
Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
[TBL] [Abstract][Full Text] [Related]
5. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
6. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
7. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).
Yoshimura M; Makiyama J; Koga T; Miyashita T; Izumi Y; Torigoshi T; Motokawa S; Eguchi K; Migita K
Clin Exp Rheumatol; 2010; 28(1):141-2. PubMed ID: 20346255
[No Abstract] [Full Text] [Related]
9. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.
Vandemergel X; Vandergheynst F
Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353
[TBL] [Abstract][Full Text] [Related]
11. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
Kadavath S; Zapantis E; Zolty R; Efthimiou P
Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
[TBL] [Abstract][Full Text] [Related]
12. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
Nishina N; Kaneko Y; Kameda H; Takeuchi T
Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
[TBL] [Abstract][Full Text] [Related]
13. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N
Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861
[TBL] [Abstract][Full Text] [Related]
14. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
[TBL] [Abstract][Full Text] [Related]
16. AA amyloidosis secondary to adult onset Still's disease: About 19 cases.
Delplanque M; Pouchot J; Ducharme-Bénard S; Fautrel BJ; Benyamine A; Daniel L; Gendre T; Grateau G; Georgin-Lavialle S
Semin Arthritis Rheum; 2020 Feb; 50(1):156-165. PubMed ID: 31488308
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
Park EH; Lee EY; Shin K; Kim HA
Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
Rech J; Ronneberger M; Englbrecht M; Finzel S; Katzenbeisser J; Manger K; Manger B; Schett G
Ann Rheum Dis; 2011 Feb; 70(2):390-2. PubMed ID: 20650873
[No Abstract] [Full Text] [Related]
20. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
